Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05933395 | Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor(GERTRUDE) | recruiting | Phase 2 | 135 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT06401421 | EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) | recruiting | — | 1,800 | Exact Sciences CorporationINDUSTRY | 2 | Jan 20, 2026 |
| clinicaltrials |
| NCT06666439 | Longitudinal Tumor Burden Quantification Using Circulating Tumor DNA in Metastatic Lobular Breast Cancer(LBC-Monitor) | recruiting | — | 20 | Julia FoldiOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07313306 | Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise | recruiting | N/A | 50 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07350928 | Observation of the Effect of Preoperative Use of Dexmedetomidine Hydrochloride Nasal Spray on Optimizing Awake Sedation During Breast-Conserving Surgery for Breast Cancer and Postoperative Awake Status | recruiting | Phase 3 | 394 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT04469296 | Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary Surgery(MACS) | recruiting | N/A | 75 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT06227728 | Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.(PTC-IMPACT) | recruiting | — | 50 | Gene SolutionsINDUSTRY | 1 | Jan 16, 2026 | clinicaltrials |
| NCT06220214 | Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer | recruiting | Early Phase 1 | 30 | Alison StopeckOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06445738 | Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)(PROSPECTIVE) | recruiting | N/A | 1,400 | Breast Cancer Trials, Australia and New ZealandOTHER | 2 | Jan 15, 2026 | clinicaltrials |
| NCT07318051 | Sample Collection for Ongoing Research and Product Evaluation Study(SCORE) | recruiting | — | 9,600 | Natera, Inc.INDUSTRY | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07331506 | Validation of the Oncoliq Test for the Early Detection of Breast Cancer. | recruiting | — | 300 | Oncoliq US IncINDUSTRY | 1 | Jan 15, 2026 | clinicaltrials |
| NCT04220970 | Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry | recruiting | — | 150 | The Lymphoma Academic Research OrganisationOTHER | 2 | Jan 14, 2026 | clinicaltrials |
| NCT06032390 | Artificial Intelligence in Mammography Screening in Norway(AIMS Norway) | recruiting | N/A | 150,000 | Norwegian Institute of Public HealthOTHER_GOV | 1 | Jan 14, 2026 | clinicaltrials |
| NCT06682195 | Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02) | recruiting | Phase 2 | 35 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT07340424 | A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer. | recruiting | Early Phase 1 | 15 | Xiaorong SunOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT07341503 | The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients | recruiting | — | 100 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT06648278 | Patient Care Outreach, Navigation, Technology and Support 2.0(COUNTS2) | recruiting | N/A | 260 | University of California, San FranciscoOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT06738966 | A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer | recruiting | Phase 1 | 9 | Shanghai Best-Link Bioscience, LLCINDUSTRY | 1 | Jan 13, 2026 | clinicaltrials |
| NCT06210776 | A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH) | recruiting | — | 800 | Daiichi SankyoINDUSTRY | 1 | Jan 12, 2026 | clinicaltrials |
| NCT06962163 | Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients(EXIGENCE) | recruiting | N/A | 12 | Institut Cancerologie de l'OuestOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT07331753 | The Outcomes of Fat Grafting Combined With Latissimus Dorsi Muscle Flap for Delayed Breast Reconstruction After Mastectomy | recruiting | N/A | 20 | Sohag UniversityOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT05490472 | JAB-2485 Activity in Adult Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 102 | Jacobio Pharmaceuticals Co., Ltd.INDUSTRY | 2 | Jan 9, 2026 | clinicaltrials |
| NCT07331363 | Evaluation of the Effect of Using Ultrasound Robots for Breast Cancer Screening: A Multicenter, Parallel-group, Cluster Randomized Controlled Trial | recruiting | N/A | 70,000 | Huazhong University of Science and TechnologyOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT06595147 | Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study(BE-FITTER) | recruiting | N/A | 60 | University of AlbertaOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06967103 | QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer | recruiting | Phase 2 | 238 | Henan Cancer HospitalOTHER_GOV | 1 | Jan 8, 2026 | clinicaltrials |
| NCT07327021 | MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC(NOGA) | recruiting | Phase 2 | 54 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06999187 | A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas | recruiting | Phase 1 | 96 | Dren BioINDUSTRY | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07002177 | A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC | recruiting | Phase 1 / Phase 2 | 196 | Forward Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06300125 | Percutaneous Cryoablation of Low-risk Early Breast Cancer(PRECICE) | recruiting | — | 234 | European Institute of OncologyOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06328465 | fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases(fREEDOM) | recruiting | N/A | 145 | European Institute of OncologyOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07049133 | Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer(Tox-DXd) | recruiting | — | 84 | European Institute of OncologyOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07080944 | Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC(SYMPHONY) | recruiting | N/A | 75 | European Institute of OncologyOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07274852 | A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors | recruiting | Phase 1 | 22 | Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jan 6, 2026 | clinicaltrials |
| NCT07321145 | A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer | recruiting | N/A | 200 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT04913064 | Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer | recruiting | N/A | 26 | City of Hope Medical CenterOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT06569706 | Feasibility and Acceptability of Endoscopic Mastectomy in Patients With Breast Cancer(NEOMAMENDO) | recruiting | N/A | 20 | University Hospital, MontpellierOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT06690840 | Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients(AZALEA) | recruiting | Phase 2 | 45 | European Institute of OncologyOTHER | 1 | Jan 5, 2026 | clinicaltrials |
| NCT04749446 | Study on Clinical Features and Outcomes of Breast Sarcoma(Breast-Sarc) | recruiting | — | 300 | Italian Sarcoma GroupNETWORK | 1 | Jan 2, 2026 | clinicaltrials |
| NCT05728268 | Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index | recruiting | Phase 2 | 64 | Shantou Central HospitalOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT05858398 | Influence of Body Composition on Chemotherapy Outcomes in Localized Breast Cancer(FATTAX) | recruiting | N/A | 48 | Centre Henri BecquerelOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT06879704 | Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer(PRECISION) | recruiting | N/A | 115 | Centre Henri BecquerelOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT07314073 | [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer | recruiting | Phase 2 | 85 | Asan Medical CenterOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT07037199 | Efficacy and Safety of Trastuzumab Rezetecan Followed by CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2-Low/Ultra-Low Advanced Breast Cancer | recruiting | Phase 2 | 45 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT07069790 | Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study(PROTECT-08B) | recruiting | N/A | 24 | Centre Paul StraussOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT06452394 | NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline | recruiting | Phase 2 | 50 | Swiss Cancer InstituteOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT06596018 | Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy | recruiting | Phase 1 / Phase 2 | 96 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07308717 | Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol | recruiting | Phase 4 | 1,896 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07310758 | Contrast-enhanced Ultrasound for Sentinel Node Detection | recruiting | Phase 2 / Phase 3 | 91 | The Netherlands Cancer InstituteOTHER | 1 | Dec 30, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Jan 20, 2026source: clinicaltrials